274 related articles for article (PubMed ID: 29858518)
21. Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: An Icelandic population-based case-control study.
Hálfdánarson ÓÖ; Fall K; Ogmundsdottir MH; Lund SH; Steingrímsson E; Ogmundsdottir HM; Zoega H
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):471-478. PubMed ID: 30565786
[TBL] [Abstract][Full Text] [Related]
22. Treatment with antipsychotics and the risk of diabetes in clinical practice.
Kessing LV; Thomsen AF; Mogensen UB; Andersen PK
Br J Psychiatry; 2010 Oct; 197(4):266-71. PubMed ID: 20884948
[TBL] [Abstract][Full Text] [Related]
23. Hospital recorded morbidity and breast cancer incidence: a nationwide population-based case-control study.
Ording AG; Garne JP; Nyström PM; Cronin-Fenton D; Tarp M; Sørensen HT; Lash TL
PLoS One; 2012; 7(10):e47329. PubMed ID: 23094045
[TBL] [Abstract][Full Text] [Related]
24. Antipsychotic Use and Risk of Breast Cancer in Women With Severe Mental Illness: Replication of a Nationwide Nested Case-Control Database Study.
Solmi M; Lähteenvuo M; Tanskanen A; Corbeil O; Mittendorfer-Rutz E; Correll CU; Tiihonen J; Taipale H
Schizophr Bull; 2024 Apr; ():. PubMed ID: 38687213
[TBL] [Abstract][Full Text] [Related]
25. Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study.
Tikk K; Sookthai D; Fortner RT; Johnson T; Rinaldi S; Romieu I; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Masala G; Krogh V; Tumino R; Ricceri F; Mattiello A; Agudo A; Menéndez V; Sánchez MJ; Amiano P; Chirlaque MD; Barricarte A; Bueno-de-Mesquita HB; Monninkhof EM; Onland-Moret NC; Andresson A; Sund M; Weiderpass E; Khaw KT; Key TJ; Travis RC; Merritt MA; Riboli E; Dossus L; Kaaks R
Breast Cancer Res; 2015 Mar; 17(1):49. PubMed ID: 25887963
[TBL] [Abstract][Full Text] [Related]
26. Risk of diabetes in children and adolescents exposed to antipsychotics: a nationwide 12-year case-control study.
Nielsen RE; Laursen MF; Vernal DL; Bisgaard C; Jakobsen H; Steinhausen HC; Correll CU
J Am Acad Child Adolesc Psychiatry; 2014 Sep; 53(9):971-979.e6. PubMed ID: 25151420
[TBL] [Abstract][Full Text] [Related]
27. Antipsychotic treatment, prolactin, and breast tumorigenesis.
De Hert M; Vancampfort D; Stubbs B; Sabbe T; Wildiers H; Detraux J
Psychiatr Danub; 2016 Sep; 28(3):243-254. PubMed ID: 27658833
[TBL] [Abstract][Full Text] [Related]
28. Breast cancer risks following antipsychotic use in women with bipolar disorder versus schizophrenia: A territory-wide nested case-control study spanning two decades.
Chu RYK; Wei Y; Osborn DP; Ng VWS; Cheng FWT; Chan SKW; Chan SSM; Wong ICK; Chan EWY; Lai FTT
Psychiatry Res; 2023 Aug; 326():115287. PubMed ID: 37320990
[TBL] [Abstract][Full Text] [Related]
29. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
31. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
[TBL] [Abstract][Full Text] [Related]
32. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
[TBL] [Abstract][Full Text] [Related]
33. Associations of parity-related reproductive histories with ER± and HER2± receptor-specific breast cancer aetiology.
Anderson WF; Pfeiffer RM; Wohlfahrt J; Ejlertsen B; Jensen MB; Kroman N
Int J Epidemiol; 2017 Feb; 46(1):86-95. PubMed ID: 27818374
[TBL] [Abstract][Full Text] [Related]
34. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.
Haddad PM; Wieck A
Drugs; 2004; 64(20):2291-314. PubMed ID: 15456328
[TBL] [Abstract][Full Text] [Related]
35. Antipsychotics and risk of first-time hospitalization for myocardial infarction: a population-based case-control study.
Nakagawa S; Pedersen L; Olsen ML; Mortensen PB; Sørensen HT; Johnsen SP
J Intern Med; 2006 Nov; 260(5):451-8. PubMed ID: 17040251
[TBL] [Abstract][Full Text] [Related]
36. Lithium, antipsychotics, and risk of psoriasis.
Brauchli YB; Jick SS; Curtin F; Meier CR
J Clin Psychopharmacol; 2009 Apr; 29(2):134-40. PubMed ID: 19512974
[TBL] [Abstract][Full Text] [Related]
37. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
[TBL] [Abstract][Full Text] [Related]
38. Antipsychotic Drugs and Risk of Hip Fracture in People Aged 60 and Older in Norway.
Bakken MS; Schjøtt J; Engeland A; Engesaeter LB; Ruths S
J Am Geriatr Soc; 2016 Jun; 64(6):1203-9. PubMed ID: 27321599
[TBL] [Abstract][Full Text] [Related]
39. Chronic long-term exposure to cadmium air pollution and breast cancer risk in the French E3N cohort.
Amadou A; Praud D; Coudon T; Danjou AMN; Faure E; Leffondré K; Le Romancer M; Severi G; Salizzoni P; Mancini FR; Fervers B
Int J Cancer; 2020 Jan; 146(2):341-351. PubMed ID: 30851122
[TBL] [Abstract][Full Text] [Related]
40. Endogenous and Antipsychotic-Related Risks for Diabetes Mellitus in Young People With Schizophrenia: A Danish Population-Based Cohort Study.
Rajkumar AP; Horsdal HT; Wimberley T; Cohen D; Mors O; Børglum AD; Gasse C
Am J Psychiatry; 2017 Jul; 174(7):686-694. PubMed ID: 28103712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
